Acute Lymphocytic Leukemia
Show Only Open Trials
1.
A Phase 1 Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
- Study Status: Open to Enrollment
- Sponsor: Tragara Pharmaceuticals
- Disease Status and/or Stage: Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) or High-risk Myelodysplasia (MDS)
2.
CALGB 10403: An Intergroup Phase II Clinical Trial for Adolescents and Young Adults With Untreated Acute Lymphoblastic Leukemia (ALL)
- Study Status: Open to Enrollment
- Sponsor: CALGB; NCI; Eastern Cooperative Oncology Group; Southwest Oncology Group
- Disease Status and/or Stage: Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
- Protocol ID: CALGB 10403
